Biotech Values

[ghmm]

would be tough to blind an injectable drug with an oral drug

As an aside, Actimmune is a 3x week injectable and it is being blinded. Its a terrible enough disease and then to receive a Placebo injection! One way this could be interpreted is the lack of options speak to what patients/docs will try (though it is available off-label). Also, this is one reason why I speculate that Pirfenidone should complete enrollment much earlier then company forecast (prior posts). One could speculate the hurdle for approval is lower as well.

** Edit **
sorry misread the part about blind injectable with Oral, thought injectable period. You can delete this post
**